nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.196	0.324	CbGbCtD
Levetiracetam—ABCB1—Lisinopril—systemic scleroderma	0.108	0.179	CbGbCtD
Levetiracetam—ABCB1—Captopril—systemic scleroderma	0.0812	0.134	CbGbCtD
Levetiracetam—ABCC2—Methotrexate—systemic scleroderma	0.0786	0.13	CbGbCtD
Levetiracetam—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0639	0.106	CbGbCtD
Levetiracetam—ABCB1—Prednisone—systemic scleroderma	0.0511	0.0845	CbGbCtD
Levetiracetam—ABCB1—Methotrexate—systemic scleroderma	0.0256	0.0424	CbGbCtD
Levetiracetam—Vomiting—Mometasone—systemic scleroderma	0.000312	0.000789	CcSEcCtD
Levetiracetam—Feeling abnormal—Azathioprine—systemic scleroderma	0.00031	0.000784	CcSEcCtD
Levetiracetam—Rash—Mometasone—systemic scleroderma	0.000309	0.000783	CcSEcCtD
Levetiracetam—Asthenia—Captopril—systemic scleroderma	0.000309	0.000782	CcSEcCtD
Levetiracetam—Dermatitis—Mometasone—systemic scleroderma	0.000309	0.000782	CcSEcCtD
Levetiracetam—Decreased appetite—Leflunomide—systemic scleroderma	0.000309	0.000781	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000309	0.000781	CcSEcCtD
Levetiracetam—Confusional state—Lisinopril—systemic scleroderma	0.000308	0.000778	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000307	0.000778	CcSEcCtD
Levetiracetam—Headache—Mometasone—systemic scleroderma	0.000307	0.000777	CcSEcCtD
Levetiracetam—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000776	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000306	0.000776	CcSEcCtD
Levetiracetam—Insomnia—Mycophenolic acid—systemic scleroderma	0.000306	0.000775	CcSEcCtD
Levetiracetam—Fatigue—Leflunomide—systemic scleroderma	0.000306	0.000775	CcSEcCtD
Levetiracetam—Pruritus—Captopril—systemic scleroderma	0.000305	0.000771	CcSEcCtD
Levetiracetam—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000304	0.00077	CcSEcCtD
Levetiracetam—Constipation—Leflunomide—systemic scleroderma	0.000304	0.000768	CcSEcCtD
Levetiracetam—Pain—Leflunomide—systemic scleroderma	0.000304	0.000768	CcSEcCtD
Levetiracetam—Infection—Lisinopril—systemic scleroderma	0.000303	0.000767	CcSEcCtD
Levetiracetam—Somnolence—Mycophenolic acid—systemic scleroderma	0.000301	0.000762	CcSEcCtD
Levetiracetam—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000301	0.000762	CcSEcCtD
Levetiracetam—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000299	0.000756	CcSEcCtD
Levetiracetam—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000298	0.000754	CcSEcCtD
Levetiracetam—Neutropenia—Prednisone—systemic scleroderma	0.000298	0.000754	CcSEcCtD
Levetiracetam—Body temperature increased—Azathioprine—systemic scleroderma	0.000297	0.000752	CcSEcCtD
Levetiracetam—Abdominal pain—Azathioprine—systemic scleroderma	0.000297	0.000752	CcSEcCtD
Levetiracetam—Skin disorder—Lisinopril—systemic scleroderma	0.000296	0.00075	CcSEcCtD
Levetiracetam—Diarrhoea—Captopril—systemic scleroderma	0.000295	0.000746	CcSEcCtD
Levetiracetam—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000294	0.000745	CcSEcCtD
Levetiracetam—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000294	0.000745	CcSEcCtD
Levetiracetam—Irritability—Methotrexate—systemic scleroderma	0.000294	0.000744	CcSEcCtD
Levetiracetam—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000293	0.000742	CcSEcCtD
Levetiracetam—Feeling abnormal—Leflunomide—systemic scleroderma	0.000293	0.00074	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000292	0.00074	CcSEcCtD
Levetiracetam—Fatigue—Mycophenolic acid—systemic scleroderma	0.000292	0.000739	CcSEcCtD
Levetiracetam—Mood swings—Methotrexate—systemic scleroderma	0.000292	0.000739	CcSEcCtD
Levetiracetam—Nausea—Mometasone—systemic scleroderma	0.000291	0.000737	CcSEcCtD
Levetiracetam—Anorexia—Lisinopril—systemic scleroderma	0.000291	0.000736	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00029	0.000735	CcSEcCtD
Levetiracetam—Weight increased—Prednisone—systemic scleroderma	0.00029	0.000734	CcSEcCtD
Levetiracetam—Ataxia—Methotrexate—systemic scleroderma	0.00029	0.000733	CcSEcCtD
Levetiracetam—Pain—Mycophenolic acid—systemic scleroderma	0.00029	0.000733	CcSEcCtD
Levetiracetam—Constipation—Mycophenolic acid—systemic scleroderma	0.00029	0.000733	CcSEcCtD
Levetiracetam—Weight decreased—Prednisone—systemic scleroderma	0.000288	0.000729	CcSEcCtD
Levetiracetam—Cough—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000723	CcSEcCtD
Levetiracetam—Dizziness—Captopril—systemic scleroderma	0.000285	0.000721	CcSEcCtD
Levetiracetam—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000284	0.00072	CcSEcCtD
Levetiracetam—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000718	CcSEcCtD
Levetiracetam—Depression—Prednisone—systemic scleroderma	0.000283	0.000717	CcSEcCtD
Levetiracetam—Abdominal pain—Leflunomide—systemic scleroderma	0.000281	0.00071	CcSEcCtD
Levetiracetam—Body temperature increased—Leflunomide—systemic scleroderma	0.000281	0.00071	CcSEcCtD
Levetiracetam—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000279	0.000706	CcSEcCtD
Levetiracetam—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000706	CcSEcCtD
Levetiracetam—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000706	CcSEcCtD
Levetiracetam—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000706	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000278	0.000703	CcSEcCtD
Levetiracetam—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000703	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000277	0.000702	CcSEcCtD
Levetiracetam—Hypersensitivity—Azathioprine—systemic scleroderma	0.000277	0.000701	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000277	0.000701	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000277	0.000701	CcSEcCtD
Levetiracetam—Insomnia—Lisinopril—systemic scleroderma	0.000276	0.000698	CcSEcCtD
Levetiracetam—Paraesthesia—Lisinopril—systemic scleroderma	0.000274	0.000693	CcSEcCtD
Levetiracetam—Vomiting—Captopril—systemic scleroderma	0.000274	0.000693	CcSEcCtD
Levetiracetam—Rash—Captopril—systemic scleroderma	0.000272	0.000687	CcSEcCtD
Levetiracetam—Dermatitis—Captopril—systemic scleroderma	0.000271	0.000687	CcSEcCtD
Levetiracetam—Somnolence—Lisinopril—systemic scleroderma	0.000271	0.000686	CcSEcCtD
Levetiracetam—Headache—Captopril—systemic scleroderma	0.00027	0.000683	CcSEcCtD
Levetiracetam—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000682	CcSEcCtD
Levetiracetam—Dyspepsia—Lisinopril—systemic scleroderma	0.000268	0.00068	CcSEcCtD
Levetiracetam—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000268	0.000678	CcSEcCtD
Levetiracetam—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000268	0.000678	CcSEcCtD
Levetiracetam—Asthma—Methotrexate—systemic scleroderma	0.000266	0.000674	CcSEcCtD
Levetiracetam—Infection—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000672	CcSEcCtD
Levetiracetam—Decreased appetite—Lisinopril—systemic scleroderma	0.000265	0.000671	CcSEcCtD
Levetiracetam—Eosinophilia—Methotrexate—systemic scleroderma	0.000264	0.000667	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000263	0.000666	CcSEcCtD
Levetiracetam—Fatigue—Lisinopril—systemic scleroderma	0.000263	0.000666	CcSEcCtD
Levetiracetam—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000663	CcSEcCtD
Levetiracetam—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000662	CcSEcCtD
Levetiracetam—Hypersensitivity—Leflunomide—systemic scleroderma	0.000262	0.000662	CcSEcCtD
Levetiracetam—Pancreatitis—Methotrexate—systemic scleroderma	0.000261	0.000661	CcSEcCtD
Levetiracetam—Pain—Lisinopril—systemic scleroderma	0.000261	0.00066	CcSEcCtD
Levetiracetam—Constipation—Lisinopril—systemic scleroderma	0.000261	0.00066	CcSEcCtD
Levetiracetam—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000657	CcSEcCtD
Levetiracetam—Diarrhoea—Azathioprine—systemic scleroderma	0.000257	0.000651	CcSEcCtD
Levetiracetam—Nausea—Captopril—systemic scleroderma	0.000256	0.000647	CcSEcCtD
Levetiracetam—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000645	CcSEcCtD
Levetiracetam—Asthenia—Leflunomide—systemic scleroderma	0.000255	0.000645	CcSEcCtD
Levetiracetam—Hallucination—Prednisone—systemic scleroderma	0.000254	0.000642	CcSEcCtD
Levetiracetam—Pancytopenia—Methotrexate—systemic scleroderma	0.000253	0.00064	CcSEcCtD
Levetiracetam—Feeling abnormal—Lisinopril—systemic scleroderma	0.000251	0.000636	CcSEcCtD
Levetiracetam—Pruritus—Leflunomide—systemic scleroderma	0.000251	0.000636	CcSEcCtD
Levetiracetam—Connective tissue disorder—Prednisone—systemic scleroderma	0.000251	0.000634	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000249	0.000631	CcSEcCtD
Levetiracetam—Neutropenia—Methotrexate—systemic scleroderma	0.000249	0.00063	CcSEcCtD
Levetiracetam—Dizziness—Azathioprine—systemic scleroderma	0.000249	0.000629	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000247	0.000626	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000616	CcSEcCtD
Levetiracetam—Asthenia—Mycophenolic acid—systemic scleroderma	0.000243	0.000615	CcSEcCtD
Levetiracetam—Diarrhoea—Leflunomide—systemic scleroderma	0.000243	0.000615	CcSEcCtD
Levetiracetam—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000612	CcSEcCtD
Levetiracetam—Body temperature increased—Lisinopril—systemic scleroderma	0.000241	0.00061	CcSEcCtD
Levetiracetam—Abdominal pain—Lisinopril—systemic scleroderma	0.000241	0.00061	CcSEcCtD
Levetiracetam—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000607	CcSEcCtD
Levetiracetam—Pruritus—Mycophenolic acid—systemic scleroderma	0.00024	0.000606	CcSEcCtD
Levetiracetam—Vomiting—Azathioprine—systemic scleroderma	0.000239	0.000605	CcSEcCtD
Levetiracetam—Eye disorder—Prednisone—systemic scleroderma	0.000238	0.000603	CcSEcCtD
Levetiracetam—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000601	CcSEcCtD
Levetiracetam—Infestation NOS—Methotrexate—systemic scleroderma	0.000237	0.000601	CcSEcCtD
Levetiracetam—Infestation—Methotrexate—systemic scleroderma	0.000237	0.000601	CcSEcCtD
Levetiracetam—Drowsiness—Methotrexate—systemic scleroderma	0.000237	0.000601	CcSEcCtD
Levetiracetam—Rash—Azathioprine—systemic scleroderma	0.000237	0.0006	CcSEcCtD
Levetiracetam—Dermatitis—Azathioprine—systemic scleroderma	0.000237	0.000599	CcSEcCtD
Levetiracetam—Depression—Methotrexate—systemic scleroderma	0.000237	0.000599	CcSEcCtD
Levetiracetam—Headache—Azathioprine—systemic scleroderma	0.000235	0.000596	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000235	0.000596	CcSEcCtD
Levetiracetam—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000595	CcSEcCtD
Levetiracetam—Dizziness—Leflunomide—systemic scleroderma	0.000235	0.000594	CcSEcCtD
Levetiracetam—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000588	CcSEcCtD
Levetiracetam—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000232	0.000586	CcSEcCtD
Levetiracetam—Stomatitis—Methotrexate—systemic scleroderma	0.000231	0.000586	CcSEcCtD
Levetiracetam—Conjunctivitis—Methotrexate—systemic scleroderma	0.000231	0.000584	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000584	CcSEcCtD
Levetiracetam—Immune system disorder—Prednisone—systemic scleroderma	0.00023	0.000583	CcSEcCtD
Levetiracetam—Pain—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000578	CcSEcCtD
Levetiracetam—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000578	CcSEcCtD
Levetiracetam—Vomiting—Leflunomide—systemic scleroderma	0.000226	0.000571	CcSEcCtD
Levetiracetam—Alopecia—Prednisone—systemic scleroderma	0.000225	0.00057	CcSEcCtD
Levetiracetam—Hypersensitivity—Lisinopril—systemic scleroderma	0.000225	0.000569	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000224	0.000568	CcSEcCtD
Levetiracetam—Dizziness—Mycophenolic acid—systemic scleroderma	0.000224	0.000567	CcSEcCtD
Levetiracetam—Epistaxis—Methotrexate—systemic scleroderma	0.000224	0.000567	CcSEcCtD
Levetiracetam—Rash—Leflunomide—systemic scleroderma	0.000224	0.000566	CcSEcCtD
Levetiracetam—Dermatitis—Leflunomide—systemic scleroderma	0.000224	0.000566	CcSEcCtD
Levetiracetam—Mental disorder—Prednisone—systemic scleroderma	0.000223	0.000565	CcSEcCtD
Levetiracetam—Nausea—Azathioprine—systemic scleroderma	0.000223	0.000565	CcSEcCtD
Levetiracetam—Headache—Leflunomide—systemic scleroderma	0.000222	0.000563	CcSEcCtD
Levetiracetam—Malnutrition—Prednisone—systemic scleroderma	0.000222	0.000562	CcSEcCtD
Levetiracetam—Agranulocytosis—Methotrexate—systemic scleroderma	0.000222	0.000561	CcSEcCtD
Levetiracetam—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000557	CcSEcCtD
Levetiracetam—Asthenia—Lisinopril—systemic scleroderma	0.000219	0.000554	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000553	CcSEcCtD
Levetiracetam—Pruritus—Lisinopril—systemic scleroderma	0.000216	0.000546	CcSEcCtD
Levetiracetam—Vomiting—Mycophenolic acid—systemic scleroderma	0.000215	0.000545	CcSEcCtD
Levetiracetam—Rash—Mycophenolic acid—systemic scleroderma	0.000214	0.00054	CcSEcCtD
Levetiracetam—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000213	0.00054	CcSEcCtD
Levetiracetam—Hepatitis—Methotrexate—systemic scleroderma	0.000213	0.000539	CcSEcCtD
Levetiracetam—Headache—Mycophenolic acid—systemic scleroderma	0.000212	0.000537	CcSEcCtD
Levetiracetam—Pharyngitis—Methotrexate—systemic scleroderma	0.000211	0.000535	CcSEcCtD
Levetiracetam—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000535	CcSEcCtD
Levetiracetam—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000535	CcSEcCtD
Levetiracetam—Nausea—Leflunomide—systemic scleroderma	0.000211	0.000534	CcSEcCtD
Levetiracetam—Vision blurred—Prednisone—systemic scleroderma	0.000209	0.000529	CcSEcCtD
Levetiracetam—Diarrhoea—Lisinopril—systemic scleroderma	0.000209	0.000528	CcSEcCtD
Levetiracetam—Agitation—Prednisone—systemic scleroderma	0.000204	0.000516	CcSEcCtD
Levetiracetam—Dizziness—Lisinopril—systemic scleroderma	0.000202	0.00051	CcSEcCtD
Levetiracetam—Erythema multiforme—Methotrexate—systemic scleroderma	0.000201	0.00051	CcSEcCtD
Levetiracetam—Nausea—Mycophenolic acid—systemic scleroderma	0.000201	0.000509	CcSEcCtD
Levetiracetam—Vertigo—Prednisone—systemic scleroderma	0.000199	0.000505	CcSEcCtD
Levetiracetam—Eye disorder—Methotrexate—systemic scleroderma	0.000199	0.000504	CcSEcCtD
Levetiracetam—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000498	CcSEcCtD
Levetiracetam—Vomiting—Lisinopril—systemic scleroderma	0.000194	0.000491	CcSEcCtD
Levetiracetam—Immune system disorder—Methotrexate—systemic scleroderma	0.000192	0.000487	CcSEcCtD
Levetiracetam—Rash—Lisinopril—systemic scleroderma	0.000192	0.000487	CcSEcCtD
Levetiracetam—Convulsion—Prednisone—systemic scleroderma	0.000192	0.000487	CcSEcCtD
Levetiracetam—Dermatitis—Lisinopril—systemic scleroderma	0.000192	0.000486	CcSEcCtD
Levetiracetam—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000192	0.000486	CcSEcCtD
Levetiracetam—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000485	CcSEcCtD
Levetiracetam—Headache—Lisinopril—systemic scleroderma	0.000191	0.000484	CcSEcCtD
Levetiracetam—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000189	0.000479	CcSEcCtD
Levetiracetam—Arthralgia—Prednisone—systemic scleroderma	0.000189	0.000478	CcSEcCtD
Levetiracetam—Myalgia—Prednisone—systemic scleroderma	0.000189	0.000478	CcSEcCtD
Levetiracetam—Anxiety—Prednisone—systemic scleroderma	0.000188	0.000477	CcSEcCtD
Levetiracetam—Alopecia—Methotrexate—systemic scleroderma	0.000188	0.000477	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000188	0.000475	CcSEcCtD
Levetiracetam—Mental disorder—Methotrexate—systemic scleroderma	0.000187	0.000472	CcSEcCtD
Levetiracetam—Malnutrition—Methotrexate—systemic scleroderma	0.000185	0.000469	CcSEcCtD
Levetiracetam—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000183	0.000463	CcSEcCtD
Levetiracetam—Nausea—Lisinopril—systemic scleroderma	0.000181	0.000459	CcSEcCtD
Levetiracetam—Infection—Prednisone—systemic scleroderma	0.00018	0.000455	CcSEcCtD
Levetiracetam—Back pain—Methotrexate—systemic scleroderma	0.000179	0.000454	CcSEcCtD
Levetiracetam—Nervous system disorder—Prednisone—systemic scleroderma	0.000178	0.00045	CcSEcCtD
Levetiracetam—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000447	CcSEcCtD
Levetiracetam—Skin disorder—Prednisone—systemic scleroderma	0.000176	0.000445	CcSEcCtD
Levetiracetam—Vision blurred—Methotrexate—systemic scleroderma	0.000175	0.000442	CcSEcCtD
Levetiracetam—Anorexia—Prednisone—systemic scleroderma	0.000173	0.000437	CcSEcCtD
Levetiracetam—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00017	0.00043	CcSEcCtD
Levetiracetam—Rash—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000426	CcSEcCtD
Levetiracetam—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000426	CcSEcCtD
Levetiracetam—Headache—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000424	CcSEcCtD
Levetiracetam—Vertigo—Methotrexate—systemic scleroderma	0.000167	0.000422	CcSEcCtD
Levetiracetam—Leukopenia—Methotrexate—systemic scleroderma	0.000166	0.00042	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000165	0.000418	CcSEcCtD
Levetiracetam—Insomnia—Prednisone—systemic scleroderma	0.000164	0.000415	CcSEcCtD
Levetiracetam—Paraesthesia—Prednisone—systemic scleroderma	0.000163	0.000412	CcSEcCtD
Levetiracetam—Cough—Methotrexate—systemic scleroderma	0.000162	0.00041	CcSEcCtD
Levetiracetam—Convulsion—Methotrexate—systemic scleroderma	0.000161	0.000407	CcSEcCtD
Levetiracetam—Dyspepsia—Prednisone—systemic scleroderma	0.000159	0.000404	CcSEcCtD
Levetiracetam—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000402	CcSEcCtD
Levetiracetam—Arthralgia—Methotrexate—systemic scleroderma	0.000158	0.0004	CcSEcCtD
Levetiracetam—Myalgia—Methotrexate—systemic scleroderma	0.000158	0.0004	CcSEcCtD
Levetiracetam—Chest pain—Methotrexate—systemic scleroderma	0.000158	0.0004	CcSEcCtD
Levetiracetam—Decreased appetite—Prednisone—systemic scleroderma	0.000157	0.000399	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000157	0.000397	CcSEcCtD
Levetiracetam—Fatigue—Prednisone—systemic scleroderma	0.000156	0.000395	CcSEcCtD
Levetiracetam—Constipation—Prednisone—systemic scleroderma	0.000155	0.000392	CcSEcCtD
Levetiracetam—Confusional state—Methotrexate—systemic scleroderma	0.000153	0.000386	CcSEcCtD
Levetiracetam—Infection—Methotrexate—systemic scleroderma	0.00015	0.000381	CcSEcCtD
Levetiracetam—Feeling abnormal—Prednisone—systemic scleroderma	0.000149	0.000378	CcSEcCtD
Levetiracetam—Nervous system disorder—Methotrexate—systemic scleroderma	0.000148	0.000376	CcSEcCtD
Levetiracetam—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000148	0.000375	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000148	0.000375	CcSEcCtD
Levetiracetam—Skin disorder—Methotrexate—systemic scleroderma	0.000147	0.000372	CcSEcCtD
Levetiracetam—Anorexia—Methotrexate—systemic scleroderma	0.000144	0.000365	CcSEcCtD
Levetiracetam—Abdominal pain—Prednisone—systemic scleroderma	0.000143	0.000362	CcSEcCtD
Levetiracetam—Body temperature increased—Prednisone—systemic scleroderma	0.000143	0.000362	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000138	0.000349	CcSEcCtD
Levetiracetam—Insomnia—Methotrexate—systemic scleroderma	0.000137	0.000347	CcSEcCtD
Levetiracetam—Paraesthesia—Methotrexate—systemic scleroderma	0.000136	0.000344	CcSEcCtD
Levetiracetam—Somnolence—Methotrexate—systemic scleroderma	0.000135	0.000341	CcSEcCtD
Levetiracetam—Hypersensitivity—Prednisone—systemic scleroderma	0.000133	0.000338	CcSEcCtD
Levetiracetam—Dyspepsia—Methotrexate—systemic scleroderma	0.000133	0.000337	CcSEcCtD
Levetiracetam—Decreased appetite—Methotrexate—systemic scleroderma	0.000132	0.000333	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000131	0.000331	CcSEcCtD
Levetiracetam—Fatigue—Methotrexate—systemic scleroderma	0.000131	0.00033	CcSEcCtD
Levetiracetam—Asthenia—Prednisone—systemic scleroderma	0.00013	0.000329	CcSEcCtD
Levetiracetam—Pain—Methotrexate—systemic scleroderma	0.000129	0.000328	CcSEcCtD
Levetiracetam—Pruritus—Prednisone—systemic scleroderma	0.000128	0.000324	CcSEcCtD
Levetiracetam—Feeling abnormal—Methotrexate—systemic scleroderma	0.000125	0.000316	CcSEcCtD
Levetiracetam—Diarrhoea—Prednisone—systemic scleroderma	0.000124	0.000314	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000124	0.000313	CcSEcCtD
Levetiracetam—Dizziness—Prednisone—systemic scleroderma	0.00012	0.000303	CcSEcCtD
Levetiracetam—Body temperature increased—Methotrexate—systemic scleroderma	0.00012	0.000303	CcSEcCtD
Levetiracetam—Abdominal pain—Methotrexate—systemic scleroderma	0.00012	0.000303	CcSEcCtD
Levetiracetam—Vomiting—Prednisone—systemic scleroderma	0.000115	0.000292	CcSEcCtD
Levetiracetam—Rash—Prednisone—systemic scleroderma	0.000114	0.000289	CcSEcCtD
Levetiracetam—Dermatitis—Prednisone—systemic scleroderma	0.000114	0.000289	CcSEcCtD
Levetiracetam—Headache—Prednisone—systemic scleroderma	0.000113	0.000287	CcSEcCtD
Levetiracetam—Hypersensitivity—Methotrexate—systemic scleroderma	0.000112	0.000282	CcSEcCtD
Levetiracetam—Asthenia—Methotrexate—systemic scleroderma	0.000109	0.000275	CcSEcCtD
Levetiracetam—Nausea—Prednisone—systemic scleroderma	0.000108	0.000272	CcSEcCtD
Levetiracetam—Pruritus—Methotrexate—systemic scleroderma	0.000107	0.000271	CcSEcCtD
Levetiracetam—Diarrhoea—Methotrexate—systemic scleroderma	0.000104	0.000262	CcSEcCtD
Levetiracetam—Dizziness—Methotrexate—systemic scleroderma	0.0001	0.000253	CcSEcCtD
Levetiracetam—Vomiting—Methotrexate—systemic scleroderma	9.63e-05	0.000244	CcSEcCtD
Levetiracetam—Rash—Methotrexate—systemic scleroderma	9.55e-05	0.000242	CcSEcCtD
Levetiracetam—Dermatitis—Methotrexate—systemic scleroderma	9.54e-05	0.000241	CcSEcCtD
Levetiracetam—Headache—Methotrexate—systemic scleroderma	9.48e-05	0.00024	CcSEcCtD
Levetiracetam—Nausea—Methotrexate—systemic scleroderma	8.99e-05	0.000228	CcSEcCtD
